Clinical Trial Update: First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients [Phase 1, Phase 2]

View source ↗

Summary

First-in-human induction treatment LIS1 studied in kidney transplant recipients; completed phase 1/2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• LIS1

Snippet

Sponsor: Xenothera SAS | Conditions: Kidney Transplant | Phase 1, Phase 2 | Status: COMPLETED